Details for New Drug Application (NDA): 040898
✉ Email this page to a colleague
NDA 040898 describes DIPYRIDAMOLE, which is a drug marketed by Chartwell Injectable, Dr Reddys, Eugia Pharma Speclts, Fresenius Kabi Usa, Hikma, Hospira, Ani Pharms, Barr, Chartwell Rx, Glenmark Generics, Impax Labs, Oxford Pharms, Purepac Pharm, Rising, Watson Labs, and Zydus Pharms Usa Inc, and is included in twenty-two NDAs. It is available from nine suppliers. Additional details are available on the DIPYRIDAMOLE profile page.
The generic ingredient in DIPYRIDAMOLE is dipyridamole. There are eighteen drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the dipyridamole profile page.
The generic ingredient in DIPYRIDAMOLE is dipyridamole. There are eighteen drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the dipyridamole profile page.
Summary for 040898
| Tradename: | DIPYRIDAMOLE |
| Applicant: | Chartwell Rx |
| Ingredient: | dipyridamole |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 040898
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 25MG | ||||
| Approval Date: | Apr 23, 2008 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 50MG | ||||
| Approval Date: | Apr 23, 2008 | TE: | RLD: | No | |||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 75MG | ||||
| Approval Date: | Apr 23, 2008 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
